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ABSTRACT
Background Pneumonia is a leading cause of death 
among children under 5 specifically in South Asia and 
sub- Saharan Africa. Hypoxaemia is a life- threatening 
complication among children under 5 with pneumonia. 
Hypoxaemia increases risk of mortality by 4.3 times in 
children with pneumonia than those without hypoxaemia. 
Prevalence of hypoxaemia varies with geography, 
altitude and severity (9%–39% Asia, 3%–10% African 
countries). In this protocol paper, we describe research 
methods for assessing impact of Lady Health Workers 
(LHWs) identifying hypoxaemia in children with signs 
of pneumonia during household visits on acceptance of 
hospital referral in district Jamshoro, Sindh.
Methods and analysis A cluster randomised controlled 
trial using pulse oximetry as intervention for children 
with severe pneumonia will be conducted in community 
settings. Children aged 0–59 months with signs of severe 
pneumonia will be recruited by LHWs during routine 
visits in both intervention and control arms after consent. 
Severe pneumonia will be defined as fast breathing and/
or chest in- drawing, and, one or more danger sign and/
or hypoxaemia (Sa02 <92%) in PO (intervention) group 
and fast breathing and/or chest in- drawing and one or 
more danger sign in clinical signs (control) group. Recruits 
in both groups will receive a stat dose of oral amoxicillin 
and referral to designated tertiary health facility. Analysis 
of variance will be used to compare baseline referral 
acceptance in both groups with that at end of study.
Ethics and dissemination Ethical approval was granted 
by the Ethics Review Committee of the Aga Khan University 
(4722- Ped- ERC-17), Karachi. Study results will be 
shared with relevant government and non- governmental 
organisations, presented at national and international 
research conferences and published in international peer- 
reviewed scientific journals.
Trial registration number NCT03588377.
INTRODUCTION
Pneumonia accounts for an estimated 18% of 
under 5 mortality across the globe.1 Majority 
of these pneumonia- specific deaths occur in 
15 countries, in which Pakistan ranks fifth.2 
Failure to seek early care and delays in hospital 
referral are commonly acknowledged deter-
minants of mortality in childhood pneumonia 
with a higher proportion reported from rural 
settings than urban.3–6 Acceptance rates of 
‘facilitated’ hospital referral advice have been 
reported low between 8% and 23% for sick 
young infants in periurban Karachi.7 8 They 
are even lower for non- facilitated referral in 
rural settings in children under 5 with severe 
pneumonia in rural Matiari district, Sindh.5 
The prominent reasons in low- income and 
middle- income countries behind this delay 
are inability to recognise seriousness of pneu-
monia, distance from health facility and lack 
of money for private healthcare.9 10
Strengths and limitations of this study
 ► Our study will directly assess impact of pulse ox-
imetry on family referral acceptance by comparing 
family acceptance of hospital referral (verbal ac-
ceptance with hospital visit) in ‘pulse oximetry and 
clinical signs’ group with ‘clinical signs alone’ group.
 ► The study has applicability because it assess-
es impact with ‘real- life’ limitations (variability in 
lady health worker accuracy in identifying severe 
pneumonia, availability of oxygen and human re-
source at referral hospital and, availability of private 
transportation).
 ► The study design provides means of minimising the 
effect of confounding.
 ► The study design avoids bias in allocation to expo-
sure groups.
 ► Blinding is not possible due to nature of intervention.
 ► Some subjects may fail to adhere to protocol and 
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In 1994, the government of Pakistan introduced the 
Lady Health Worker (LHW) programme in rural popu-
lations with low physician density to address common 
health problems in women and children under 5 through 
household visits. To date, a team of over 110 000 LHWs are 
working for the programme nationwide with 23 185 LHWs 
in Sindh alone.11 Each LHW is responsible for a popula-
tion of 1000–1500 individuals (catchment of about 100 
families). Recruits are preferably local, with a minimum 
of 8 years of formal schooling, followed by 15 months of 
training to deliver maternal and child healthcare (MCH) 
in community settings. During a monthly home visit, the 
LHW provides essential MCH services including family 
planning needs, nutritional assessments of both mother 
and child, management of minor and common illnesses, 
improving immunisation coverage and imparting health 
education.12
This study recognises the LHW as a powerful conduit for 
reaching under 5 children at household level and identi-
fying severe pneumonia in under five at an early stage. It 
also recognises the underestimation of hypoxaemia (arte-
rial oxygen saturation, SpO2 of <90%), a major risk factor 
for pneumonia mortality at community level and assesses 
its prevalence. The reported prevalence of hypoxaemia 
in under 5 acutely ill children is 5%–58% in facilities13–16 
and 16%–39% in community settings.17 A 4.3- time higher 
risk of mortality has been associated with pneumonia with 
hypoxaemia than in children with pneumonia without 
hypoxaemia.13 Hypoxaemia is also predictive of treatment 
failure with amoxicillin in children aged 3–59 months.18 
In resource- poor settings where pulse oximetry is not 
feasible, signs and symptoms of severe pneumonia (sleep-
iness, cyanosis, head nodding/grunting and inability to 
move) are used as predictors of hypoxaemia. However, 
the validity of clinical signs to predict hypoxaemia varies 
and it is often difficult for physicians working in settings, 
where objective detection of hypoxaemia is not available, 
to decide whether the child coming with severe pneu-
monia requires administration of oxygen or not.15 19 20
Pulse oximetry16 is a rapid, portable, non- invasive and 
accurate method of measuring Sp02 and has therefore 
been used in trial and clinical settings to detect hypox-
aemia. Appropriate oxygen therapy (based on PO find-
ings rather than clinical signs of severity alone) has been 
associated with lower mortality risk.19 Assuming access 
to supplemental oxygen, PO could potentially avert up 
to 148 000 severe pneumonia- related deaths if imple-
mented, and, combining PO with IMCI assessment for 
pneumonia has been shown to be cost- effective in 15 high 
burden countries.21 Emdin et al found first level LHWs 
in periurban Karachi could easily perform pulse oxim-
etry on young infants on well and sick visits to a primary 
healthcare facility.22
Over the past decade, the possible impact of pulse oxim-
etry in hospital and community settings has been of interest 
across the globe. Health survey of 54 countries in 2010, 
suggested that 19.2% of the operating theatres around 
the globe are not equipped with pulse oximeters.23 Trials 
assessing utility of pulse oximetry on a health systems level 
in Nigeria have shown that health workers reserve PO for 
the sickest patients.24 25 This has also been observed in 
areas at higher altitudes with higher prevalence of hypox-
aemia (highlands of Papua New Guinea).25 26 There is 
lack of clarity about how pulse oximetry can be used in 
the community where lower hypoxaemia prevalence may 
be a lesser incentive for health workers to use PO such as 
in interior Sindh settings in Pakistan. Then again, health 
workers recruited from within communities may be 
better invested and motivated than hospital personnel in 
following case management guidelines precluding PO. It 
is, therefore, worthwhile to explore and describe contexts 
behind a family’s acceptance (or not) of referral advice 
whether based on technology and/or clinical examina-
tion in rural settings where the highest burden of pneu-
monia deaths lies.
Feasibility and sustainability audits of oxygen delivery 
systems in the Gambia and Egypt have shown that 
providing technology alone is ineffective, and should 
preclude provision of supplies, education, training and 
feedback.27–30 This protocol paper describes a study to 
assess the effect of PO monitoring in community settings 
on hospital referral acceptance in children under 5 with 
severe pneumonia.
METHODS
Study aims and design
The overall aim of the study is to assess if detection of 
hypoxaemia, and/or severe pneumonia in children 0–59 
months by LHWs during their monthly home visits will 
increase hospital referral acceptance among families in 
district Jamshoro, Sindh, Pakistan.
Primary objectives are:
1. To assess and compare the impact of ‘pulse oximetry’ 
used by LHWs at household level on increasing hos-
pital referral acceptance rates in intervention clusters 
(district Jamshoro) for children aged 0–59 months 
with severe pneumonia with the impact of LHWs using 
clinical signs alone in non- intervention clusters of the 
same district.
2. To investigate the likely predictors (demographic, clin-
ical) of hospital referral acceptance in both the groups.
Secondary objective is:
3. To compare clinical outcomes (treatment comple-
tion, treatment failure, hypoxaemia) of children 0–59 
months who accepted referral to those who refused ad-
mission and were treated at home.
A community- based cluster randomised trial will be 
conducted in district Jamshoro, among children of ages 
0–59 months (figure 1). In intervention areas, all children 
with cough, fever or difficulty in breathing (acute respira-
tory illness) will be assessed for study eligibility (signs 
and symptoms of severe pneumonia, or hypoxaemia 
alone, or severe pneumonia with hypoxaemia) by LHWs 
during their monthly home visit in their catchment area. 
In control areas, study eligibility will require detection of 
copyright.
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signs of severe pneumonia alone (online supplemental 
appendix 1) during LHW monthly visits. Data will be 
collected on demographics, likely predictors and clinical 
outcomes using a structured questionnaire.
The primary outcome is hospital referral acceptance in 
children under 5 with severe pneumonia and to identify 
demographic and clinical predictors of hospital referral 
acceptance. The predictors will include distance of child 
home to referral facility, socioeconomic status of house-
hold, parental education, child age, nutritional status, 
respiratory rate, temperature, hypoxaemia and presence 
of other illnesses.
Secondary outcomes include duration of oxygen 
therapy, treatment failure, duration of hospital stay, vital 
and health status of child at day 7th and 14th.
Trial setting
The study will be conducted within the community of 
Taluka Kotri in District Jamshoro, Sindh (figure 2). Jams-
horo District has a population of 993 142.31 It is predom-
inantly rural, with 33% literacy, and >50% employed 
daily wage labourers. A baseline survey conducted as a 
part of current study showed the status of overall health 
indicators: skilled birth attendance 57%, antenatal care 
coverage 75%, postnatal care cover for mother and 
newborn within 48 hours 31.5%, vaccination complete-
ness in children 12–23 months 68% and care seeking for 
ARI and diarrhoea >80% (internal survey). A total of 27 
health facilities function in the district including 1 district 
headquarter (DHQ) hospital, 3 taluka headquarter hospi-
tals, 5 rural health centres and 18 basic health units. The 
district is divided administratively in 30 union councils. 
Kotri is one of the four Talukas of Jamshoro, consists of 
44% (437 561) of the population of district.31
Participants will be the permanent residents of Kotri, 
Jamshoro and recruited from their homes during routine 
monthly visits by LHWs serving in their catchment areas. 
This study is expected to run for 48 months with partici-
pant identification and enrolment conducted simultane-
ously in intervention and control clusters over 21 months 
after an initial pilot of 1 month. Each enrolled child will 
be revisited at day 7 and 14 for outcome measurement.
Participant
Any child aged 0–59 months having signs and symptoms 
of acute respiratory illness (cough, fever, difficulty in 
breathing) in intervention clusters will undergo assess-
ment of (1) signs and symptoms of severe pneumonia and 
(2) pulse oximetry during monthly LHW home visits. Pres-
ence of severe pneumonia with or without hypoxaemia, 
or hypoxaemia alone will merit hospital referral (non- 
facilitated). Any child aged 0–59 months having signs and 
symptoms of acute respiratory illness (cough, fever, diffi-
culty in breathing) in control clusters will undergo assess-
ment of (1) signs and symptoms of severe pneumonia 
alone. Presence of severe pneumonia will merit hospital 
referral (non- facilitated). Exclusion criteria will include 
lack of consent and, non- availability (lost to follow- up, 
migration) on days of scheduled follow- up visits (days 7 
and 14). Those who accepted referral but did not show 
up at hospital will be included in final analysis.
Randomisation and masking
Study clusters were defined as the area covered by an 
LHW. Each LHW covers a minimum of 100 households. 
Figure 1 Trial profile. LHW, Lady Health Worker, PO, Pulse 
Oximetry.
Figure 2 Map of intervention and control sites Abbreviations 
used in Map: Liaqat University of Medical and Health 
Sciences Jamshoro (LUMHS). Legend: Lady Health Worker 
(LHW). Service Layer Credits: Companies/institutes which 
contributed and collaborated to make this basemap publicly 
available (Environmental Systems Research Institute (ESRI), 
HERE (private company), General Bathymetric Chart of the 
Oceans (GEBCO), US Geological Survey (USGS), Food and 
Agriculture (FAO), National Park Service (NPS), National 
Resources Canada (NRCan), GeoBase, Institut Geographique 
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A list of LHWs working in Kotri was collected from the 
LHW programme, health department government of 
Sindh. There are a total of 188 active LHWs in the study 
site. A baseline survey was conducted to collect data on 
health indicators from the LHW catchments. The clus-
ters were randomly allocated to intervention and control 
groups on 1:1 fashion with a computer- generated rando-
misation sequence that was generated by an independent 
expert. Clusters were matched on under 5 population 
and distance to referral health facility. No stratification 
was used for allocation; clusters were selected to ensure 
that the reporting and training centres of intervention 
and control LHWs were separate. The investigators and 
the national and provincial LHW programme coordina-
tors will be excluded from the allocation process.
Training of LHWs
The LHW programme of Pakistan consists of a community- 
based group of first- level health workers with the prin-
cipal mandate of home- based maternal and child health. 
The recruitment process is well defined and selection 
criteria include: at least 8 years of education with middle 
school pass, local residency, recommendation from the 
community and preferably married.32 Once selected, they 
receive 15 months of basic training in mid- wifery and 
family planning using standardised training manuals and 
curriculum, and periodic refresher training courses. Each 
of these LHWs is typically responsible for approximately 
1000 people, or 150 homes, and often serve as the primary 
healthcare contact in these rural communities.32 33
We chose LHWs as study personnel due to their access 
to homes on regular monthly basis. We trained interven-
tion and control LHWs in separate groups for all of the 
following: (1) classification of ARI (no pneumonia, pneu-
monia, severe pneumonia) using standard acute respira-
tory infections training modules (WHO and IMNCI), (2) 
identification of danger signs and (3) case management 
of pneumonia at home with oral amoxicillin and severe 
pneumonia with stat dose of antibiotic before hospital 
referral. Intervention LHWs received an additional 
training in using a pulse oximeter and obtaining a valid 
reading. The principal investigator (PI) led these training 
sessions with senior trainers of the LHW programme 
(lady health supervisors).
Participant recruitment and study procedures
Intervention delivery
Children aged 0–59 months with cough and/or diffi-
cult breathing during regular home visits of LHWs will 
be assessed for first, signs and symptoms of severe pneu-
monia (fast breathing/chest in- drawing and one or more 
danger sign (unable to eat/drink, vomiting, convulsion 
and lethargy/unconsciousness) and/or stridor)) and 
second, hypoxaemia (SpO2 <92%) using a handheld 
pulse oximeter (Masimo Rad- 5v) to measure blood oxygen 
saturation level. LHWs will also do case management of 
children with pneumonia and severe pneumonia. A 3- day 
course of oral amoxicillin will be given to children with 
pneumonia at home, whereas children meeting referral 
criteria (severe pneumonia alone, hypoxaemia alone 
or severe pneumonia and hypoxaemia) after obtaining 
informed consent (online supplemental appendix 2), 
will be administered a stat dose of oral amoxicillin and 
referred to nearest referral hospital (DHQ Kotri).
The study investigators will have provided these pulse 
oximeters to the LHW programme in advance and high-
lighted which ones will receive them. Physicians at the 
referral centre serving the intervention clusters will also 
receive handheld pulse oximeters. All the LHWs and 
staff will be trained on the use, and maintenance of these 
pulse oximeters. Children with severe pneumonia with or 
without hypoxaemia will be advised to go to hospital for 
antibiotics and oxygen, using the PO reading as a tool 
to convince parents. Children with hypoxaemia alone, 
without signs of severe pneumonia, will be referred to 
hospital to rule out cyanotic congenital heart disease. 
Name of the predesignated health facility with avail-
able oxygen and study physician will be provided to 
all the LHWs so that Study Workers (non- LHW study 
personnel) can coordinate with study physicians and 
ensure the patient has reached and is receiving safe and 
recommended care at referral facility. Project staff will 
pretest and regularly monitor PO accuracy and quality of 
readings.
Hypoxaemia will be defined as an SpO2 <92%. SpO2 
measurement will be recorded after 1 min of stable obser-
vation. If the SpO2 comes 92% or less, the child will first 
be assessed for nasal obstruction with readings repeated 
after applying nasal saline drops. If repeat reading shows 
hypoxaemia, the child will be referred to nearest desig-
nated referral hospital and admitted for oxygen via nasal 
or nasopharyngeal route and intravenous antibiotics, as 
per recommendations.
Implementation of active control: clinical signs assessment
Children aged 0–59 months with cough and/or difficult 
breathing during regular home visit will be assessed by 
LHWs for signs and symptoms of severe pneumonia (fast 
breathing/chest in- drawing and one or more danger sign 
(unable to eat/drink, vomiting, convulsion and lethargy/
unconsciousness) and/or stridor)). A 3- day course of oral 
amoxicillin will be given to children with pneumonia at 
home, whereas children with severe pneumonia (eligible 
for recruitment) will be requested for informed consent 
and offered stat dose of oral amoxicillin and referral to 
nearest referral hospital.
Procedure at referral facility
Children who accept hospital referral in both interven-
tion and control clusters and reach hospital premises 
with LHW referral slip will be assessed by study physi-
cian at the referral centre. An SMS notification with 
brief details of referred child will have been provided to 
trained study personnel (study physician) in advance at 
time of referral at both the referral facilities. Children 
with severe pneumonia and/or hypoxaemia as per LHWs 
copyright.
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who reach referral hospital premises will be examined 
and subjected to pulse oximetry again by the study physi-
cian at referral facility. If signs and symptoms of severe 
pneumonia are present, the child will be admitted for 
further appropriate treatment (oxygen therapy via nasal 
or nasopharyngeal route and intravenous antibiotics, etc) 
and if the symptoms are not severe (absence of danger 
sign), the child will be treated in outpatient care as per 
the standard of referral facility. All the children admitted 
at referral facility will undergo 12 hourly monitoring by 
study personnel and filling of CRF and hospital physi-
cian form (HPF) at days 1, 7 and 14. Those children who 
refused the referral will be visited by study community 
health workers after 24 hours to confirm referral refusal 
and to fill CRF.
Preliminary meetings will be held with the executive 
director health Jamshoro, director general health Sindh, 
in- charge LHW programme Sindh and in- charge paedi-
atric units LUMHS to ensure their cooperation through 
study duration. Emergency and paediatric unit staff at 
the referral facilities along with study personnel (physi-
cian/nurse) will be trained on management of severe 
pneumonia according to the integrated management of 
neonatal and childhood illnesses (IMNCI) guidelines.34 
A baseline survey will be conducted at the health facili-
ties to ensure availability of oxygen and necessary intra-
venous antibiotics. Even though it is ideal to guarantee 
sustainable oxygen systems at the two chosen referral 
public sector hospitals, this study does not provide 
oxygen, and therefore, aims to assess ‘real- life’ situations 
in public hospitals and their impact on severe pneu-
monia outcomes with or without hypoxaemia. LHWs will 
be incentivised on basis of their contribution to the study 
activities.
Data collection and storage
Data will be collected by LHWs during house visits 
(screening form), community health workers (during 
follow- up visits days 1, 7 and 14) and hospital- based 
study personnel (for all who accept referral and reach 
hospital premises) on paper forms (online supplemental 
appendix 3). Given that it will be a new experience for 
LHWs to assess, classify and manage ARI cases and at the 
same time record findings on data forms accurately, these 
will be supervised closely and frequently, at least for the 
first pneumonia season. Well trained study field super-
visory officers and LHW supervisors will be required 
to perform regular field supervision in their respective 
clusters and ensure accurate and logically entered data 
forms and make necessary verifications and corrections 
at the data collection sites and give feedback to the LHW 
to avoid repeating the errors. Raw data brought to the 
programme office will be checked once again for accu-
racy by the technical staff and approved for entry in the 
computer. All raw data will be safely kept in the AKU 
office, appropriately numbered by cluster, until 7 years 
after the study is over.
Case history records
These include the study CRF and HPF that will contain 
information that documents the child’s eligibility to 
participate in the study, the signed consent form and 
information from tests and examinations. Wherever 
possible copies of supporting documentation for the 
information contained in the CRF should be kept with 
each patient’s case history record. This supporting docu-
mentation may include records of physical examinations, 
progress notes, laboratory reports, X- rays, consultations, 
correspondence, information and data on the subject’s 
condition, during and after the clinical investigation, 
diagnoses made, concomitant therapy, etc. All informa-
tion in the case history records should be attributable 
to a specific individual. Since the CRF will not contain 
the patient’s name, there will be a unique link between 
the ID number on the CRF and the patient’s name. Each 
child’s case history record will be evaluated to verify 
validity and completeness of the data on the CRF when a 
study monitor visits the study site. All corrections to CRF’s 
must be made without obscuring the original entry. The 
revised entry should be inserted and the person making 
the correction should sign and date the correction. Only 
authorised study personnel may complete or correct 
CRFs.
Data management
Screening data will be collected on paper by LHWs. 
CRF and HPF will be collected on electronic forms. To 
ensure proper implementation of the intervention, the 
field supervisors will make spot checks and will arrange 
monthly refresher group sessions of the first- line health 
workers in which the problems encountered will be 
discussed and resolved. In addition, the data collection 
activity will be carried out by teams consisting of LHWs/
CHWs and study staff will be further monitored by field 
supervisors who will perform a check on a subset (5%) of 
households.
An information system will be set up to keep track 
all patients screened and enrolled and a filing system 
to keep all study related records—case history records, 
study protocol or related documentation and drug 
distribution records. The coordinator at the site will be 
responsible for the completeness and accuracy of all the 
study materials.
Study protocol and related documentation
All study- related documents including the study 
protocol, manuals of operations, all correspondence 
sent to or received from the study monitor, materials 
used for obtaining informed consent, protocol modi-
fications and records of the institutional review board 
(IRB) approval and all communications with the IRB 
must be maintained in complete form. These docu-
ments will be evaluated to ensure that study documenta-
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Record retention
Retention of accurate and complete records is essential 
to establish the validity and completeness of the study. 
All records must be retained for 7 years after the data set 
is frozen. Electronic data will be deidentified, unlinked 
from any personal identifiers and therefore will protect 
individual identity.
Reporting of serious adverse events and treatment failures
Amoxicillin is in widespread use and is not investigational 
in any study site. However, since oral amoxicillin is not 
routinely recommended for initial treatment of children 
who have severe pneumonia, the appropriate case report 
forms (CRFs) describing the occurrence of a serious 
adverse event, treatment failure or death must be faxed to 
the coordinating centre within 72 hours of the site coordi-
nator knowing about the event. Adverse events, treatment 
failure and death must be reported to allow appropriate 
interpretation of this critical information. If the outcome 
of the adverse event is unknown when the site coordi-
nator first notifies the coordinating centre, a follow- up 
form must be faxed to the coordinating centre within 10 
days of knowing about the event. The PI should send a 
copy of the adverse event data to their local IRB as soon 
as possible. The coordinating centre will summarise the 
adverse event and death information and send a report to 
the IRB/ERC of sponsors and to site IRBs. Both the rate 
of adverse events and the rate of patient accrual at each 
individual site will be monitored to determine if stopping 
rules are met. We do not anticipate serious adverse events. 
However, in case of one, a DSMB will be requested for 
and convened on ad hoc basis for safety review at any time 
during the study if there is a concern regarding rates of 
adverse events or rates of patient accrual. Adverse events 
will be reported by the study physician to the PI and clini-
cally managed by the study physician in conjunction with 
other physicians at the institution. Any related and unex-
pected life- threatening adverse event including death will 
be reported to the IRB within two business days as per IRB 
protocol and any related, unexpected and serious adverse 
event will be reported to the IRB within 10 business days 
as per IRB protocol.
Compliance with and deviations from the study protocol
The site coordinator must agree with and sign the 
protocol and confirm in writing that he or she has read, 
understands and will work according to the protocol and 
Good Clinical Practice. The site coordinator is respon-
sible for making sure that the protocol is strictly followed 
and should not make any changes to the study unless 
necessary to eliminate an apparent immediate hazard or 
damage to a trial subject. Any deviations from the study 
protocol including but not limited to inappropriate 
enrolment of a study subject, administration of the wrong 
study treatment, missed doses of study treatment, missed 
observation points, incorrect administration of concom-
itant medications, etc should be reported to the coor-
dinating centre and each site’s IRB. The report should 
include a plan to rectify any problems at the site that may 
have caused the protocol deviation.
Sample size
Defining a cluster as (the catchment area of) one LHW, 
and assuming a power of 90% in detecting 50% increase 
in referral acceptance from a 10% baseline to 15% among 
children aged 0–59 months with severe pneumonia 
(pneumonia prevalence at 2- week recall (MICS Sindh): 
7.5% (18% of which is assumed severe pneumonia) with 
ICC 0.001736. We need to capture a total of 4160 children 
with severe pneumonia in both intervention and control 
groups.
Data analysis
The primary analysis for each outcome will perform on 
an ‘intention- to- treat’ basis, that is, all children included 
in the analysis who were enrolled in the study according 
to the group to which they were allocated. All analyses 
will account for the cluster randomised design to ensure 
correct type I error rates and CIs.35 Baseline characteris-
tics will be compared by analysing differences in means 
and proportions among the study arms. Categorical 
outcomes will be compared using χ2 test and continuous 
outcomes using Student’s t- test. For analysis of predic-
tors of referral acceptance, generalised linear model will 
be used with logit link function. The univariate analysis 
will be conducted to explore the independent effect of 
each predictor on outcome. The variables significant at a 
liberal p <0.20 will be included in multivariate model for 
adjustment. The results will be reported as relative risk 
with 95% CI. Type 1 error will be set at 5% level. All anal-
ysis will be done using STATA V.15.
Patient and public involvement
Patients or the public will not be involved in the design or 
conduct of the study. Results will be disseminated to the 
community.
Study status
Recruitment began in August 2019 and field activities and 
data collection are in process. As of 16 October 2020, a 
total of 235 cases and 184 controls have been enrolled. 
Extension of study duration is in discussion to achieve 
sample size.
DISCUSSION
Hypoxaemia, a frequent complication of severe pneu-
monia, is a major risk factor for death in children under 
5. Theoretically, detection of hypoxaemia at community 
level among severe pneumonia cases by the use of pulse 
oximeter would give awareness to the caregivers about 
severity of illness and reduce delay in hospital referral. 
Delayed care- seeking is a recognised risk factor in pneu-
monia mortality in community settings.36 Unfortunately, 
information on prevalence of hypoxaemia, effectiveness 
of its detection in influencing parents to seek hospital 
care (gold standard for severe pneumonia) and impact 
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of appropriate care at hospital in settings like Pakistan is 
lacking. Thus, the findings of this study will build evidence 
for utility of providing front- line workers like LHWs with a 
tool to detect hypoxaemia if signs and symptoms of pneu-
monia are present. Interestingly various groups across 
the world are now espousing pulse oximetry with other 
strengths like detection of congenital heart disease37 38 
and newborn sepsis.39
Limitations
Some union councils with poor LHW coverage were not 
included in this study. This was a compromise on gener-
alisability in favour of feasibility. It may have led to exclu-
sion of children whose referral patterns were important to 
gauge. We also did not offer facilitated referral in either 
arm. This may have affected referral acceptance in both 
groups, however, will allow assessment of real- life impact 
of transportation barriers.
Though we kept hospital referral (as recommended by 
WHO) for severe pneumonia as our standard of care, it 
was beyond the scope of this study to ensure that referral 
centres had sustainable oxygen systems/capacity for non- 
invasive ventilation in children with severe pneumonia, 
or readily available cardiac evaluation resources for chil-
dren with hypoxaemia alone. Duke et al showed improved 
case fatality rates by providing oxygen concentrators and 
pulse oximeters at five hospitals in PNG along with proto-
cols for use.35 Lack of quality care at referral hospitals in 
developing countries is a recognised barrier to healthcare 
seeking behaviour.40 41
If our study reveals pulse oximetry has influenced 
health- seeking behaviour significantly, we will need to 
follow with a more systematic evaluation of pneumonia 
care at rural hospitals which vary in quality of care. We 
will also need to correlate recovery rates in those who 
accepted hospital referral versus those who stayed home 
on oral amoxicillin. Evidence to support home care for 
severe pneumonia is poor.42
The COVID-19 pandemic has adversely affected 
recruitment in the study with disruption of field activities 
for many months in 2020. We anticipate prolongation of 
study duration in order to achieve sample size.
ETHICS AND DISSEMINATION
This study has been approved by the Ethical Review 
Committee of The Aga Khan University (4722- Ped- ERC-
17), Karachi, Pakistan in June 2017. Written informed 
consent in the local language will be obtained from 
parents or guardians of all participants. Data forms will 
contain no identifying information other than age, sex 
and GIS coordinates. Laboratory forms will contain no 
identifying information, specimens will be identified by 
a study number only and test results will not be linked to 
any individual by name. All survey staff will sign a confi-
dentiality agreement to ensure that they do not release 
participant identities and test or study results to individ-
uals who are not part of the study team.
Study progress and findings will be shared with spon-
sors (BMGF) quarterly. Results will be presented at 
national and international research meetings and confer-
ences and also prepared for publication in international 
peer- reviewed scientific journals. Study findings will be 
disseminated to the study communities.
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